| RS1554160246 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic acidemia |
| RS1554160638 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic acidemia |
| RS1554160743 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency, Methylmalonic acidemia |
| RS1554160919 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS1554161054 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS1554161865 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Salla disease |
| RS1554162016 |
ELOVL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 34, ELOVL4-related disorder |
| RS1554162178 |
ELOVL4
|
Health Risk |
Likely pathogenic |
— |
| RS1554162230 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Salla disease |
| RS1554162301 |
ELOVL4
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia type 34, Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome |
| RS1554162524 |
ELOVL4
|
Health Risk |
Likely pathogenic |
Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome, ELOVL4-related disorder |
| RS1554162725 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1554162761 |
H1-4
|
Health Risk |
Likely pathogenic |
— |
| RS1554162842 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Salla disease |
| RS1554162872 |
H1-4
|
Health Risk |
Pathogenic |
Rahman syndrome, Rahman syndrome |
| RS1554162894 |
H1-4
|
Health Risk |
Pathogenic |
Rahman syndrome, Rahman syndrome |
| RS1554163591 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease 4, Autosomal recessive polycystic kidney disease |
| RS1554163878 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Salla disease |
| RS1554163919 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 25, Retinitis pigmentosa |
| RS1554163929 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1554163945 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS1554163958 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Salla disease |
| RS1554163993 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS1554164078 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Salla disease |
| RS1554164096 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS1554164322 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Salla disease |
| RS1554166294 |
SLC35A1
|
Health Risk |
Pathogenic |
SLC35A1-congenital disorder of glycosylation, SLC35A1-congenital disorder of glycosylation |
| RS1554166844 |
SLC35A1
|
Health Risk |
Pathogenic/Likely pathogenic |
SLC35A1-congenital disorder of glycosylation, SLC35A1-congenital disorder of glycosylation |
| RS1554167673 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1554168326 |
COL12A1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Global developmental delay |
| RS1554169267 |
CILK1
|
Health Risk |
risk factor |
Epilepsy, juvenile myoclonic |
| RS1554169280 |
FARS2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 14, Combined oxidative phosphorylation defect type 14 |
| RS1554169319 |
COL12A1
|
Health Risk |
Likely pathogenic |
— |
| RS1554169353 |
FARS2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 14, Combined oxidative phosphorylation defect type 14 |
| RS1554169460 |
CSNK2B
|
Health Risk |
Pathogenic |
— |
| RS1554169462 |
CSNK2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Poirier-Bienvenu neurodevelopmental syndrome, Poirier-Bienvenu neurodevelopmental syndrome |
| RS1554169567 |
PKHD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1554169630 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1554169967 |
CSNK2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Poirier-Bienvenu neurodevelopmental syndrome |
| RS1554169984 |
CSNK2B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, 12 conditions |
| RS1554169990 |
CSNK2B
|
Health Risk |
Pathogenic |
— |
| RS1554171033 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1554174425 |
RHAG
|
Health Risk |
Pathogenic |
Overhydrated hereditary stomatocytosis, Overhydrated hereditary stomatocytosis |
| RS1554174796 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1554174903 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1554176343 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1554176504 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1554176517 |
PKHD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1554180622 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1554181192 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1554181203 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease |
| RS1554181304 |
CD2AP
|
Health Risk |
Pathogenic |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, Focal segmental glomerulosclerosis 3 |
| RS1554182368 |
PROP1
|
Health Risk |
Likely pathogenic |
Pituitary hormone deficiency, combined |
| RS1554182405 |
PROP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary hormone deficiency, combined |
| RS1554182481 |
PROP1
|
Health Risk |
Pathogenic |
Pituitary hormone deficiency, combined |
| RS1554182507 |
PROP1
|
Health Risk |
Likely pathogenic |
Pituitary hormone deficiency, combined |
| RS1554182514 |
PROP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary hormone deficiency, combined |
| RS1554182632 |
PROP1
|
Health Risk |
Pathogenic |
Pituitary hormone deficiency, combined |
| RS1554182645 |
PROP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary hormone deficiency, combined |
| RS1554182935 |
COL12A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1554183012 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1554183097 |
PKHD1
|
Health Risk |
Pathogenic |
— |
| RS1554183204 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1554183235 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1554183240 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1554183320 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1554183398 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1554183432 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1554183440 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1554183446 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1554183480 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1554183559 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1554183588 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1554183763 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1554184177 |
MAP3K7
|
Health Risk |
Likely pathogenic |
— |
| RS1554184224 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1554184237 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1554185405 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS1554186385 |
GUCA1A;GUCA1ANB-GUCA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Cone dystrophy 3 |
| RS1554186441 |
GUCA1A;GUCA1ANB-GUCA1A
|
Health Risk |
Pathogenic |
Cone dystrophy 3, Cone dystrophy 3 |
| RS1554186463 |
GUCA1A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1554186472 |
GUCA1A;GUCA1ANB-GUCA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy, Cone-rod dystrophy |
| RS1554186583 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 2, Ullrich congenital muscular dystrophy 2 |
| RS1554189042 |
NSD1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554189131 |
NSD1
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1554189269 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS1554189447 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease type 1A, Maple syrup urine disease type 1A |
| RS1554189482 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS1554189490 |
NSD1
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Sotos syndrome |
| RS1554189512 |
NSD1
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Sotos syndrome |
| RS1554189720 |
NSD1
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS1554189871 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS1554189879 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS1554189941 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS1554189972 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS1554190214 |
NSD1
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Sotos syndrome |
| RS1554190247 |
NSD1
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Sotos syndrome |
| RS1554190262 |
NSD1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554190269 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS1554190292 |
NSD1
|
Health Risk |
Pathogenic |
— |